Insiders Updates
Inhibrx Biosciences Inc.’s latest rating changes from various analysts
In a filing, Inhibrx Biosciences Inc. revealed its Director Kayyem Jon Faiz acquired Company’s shares for reported $1.0 million on
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.